Error: Could not add to watchlist. X

BB Adamant Global Biotech

+ Watchlist
ADGLBII:SW
3,577.49
CHF
168.35
4.94%
As of 11:30:00 ET on 08/27/2015.
Fund Type
Open-End Fund
52Wk Range
2,672.35 - 4,161.45
1 Yr Return
22.65%
YTD Return
6.55%
Previous Close
3,409.14
52Wk Range
2,672.35 - 4,161.45
1 Yr Return
22.65%
YTD Return
6.55%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 08/27/2015)
3,577.49
Total Assets (m CHF) (on 08/27/2015)
152.720
Inception Date
10/15/2010
Last Dividend (on 12/05/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.24%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 37.00 k 12.96 m 8.65
Celgene Corp 115.00 k 11.64 m 7.77
Gilead Sciences Inc 120.00 k 11.30 m 7.54
Amgen Inc 76.00 k 11.24 m 7.50
Regeneron Pharmaceuticals Inc 25.00 k 10.71 m 7.15
Vertex Pharmaceuticals Inc 65.00 k 7.51 m 5.01
Mylan NV 110.00 k 7.45 m 4.97
Isis Pharmaceuticals Inc 130.00 k 6.91 m 4.61
Illumina Inc 40.00 k 6.90 m 4.61
Kite Pharma Inc 135.00 k 6.37 m 4.25
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
ADDRESS
Balfidor Fondsleitung AG
Peter-Merian Strasse 47
CH 4002 Basel
Switzerland
PHONE
+41 800 850 050